Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit T Priest

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Opinion in Drug Discovery & Development|September 9, 2009
Future potential and status of selective sodium channel blockers for the treatment of painBirgit T Priest
Future Medicinal Chemistry|October 28, 2017
The therapeutic potential of targeting the K<sub>ir</sub>1.1 (renal outer medullary K<sup>+</sup>) channelBirgit T Priest, Alexander Pasternak
Frontiers in Pharmacology|December 19, 2014
Phenotypic screening in the 21st centuryBirgit T Priest, Gul Erdemli
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Subtype-selective sodium channel blockers promise a new era of pain researchBirgit T Priest, Gregory J Kaczorowski
Expert Opinion on Therapeutic Targets|February 15, 2007
Blocking sodium channels to treat neuropathic painBirgit T Priest, Gregory J Kaczorowski
Channels (Austin, Tex.)|November 12, 2015
Cardiac ion channelsBirgit T Priest, Jeff S McDermott
Channels (Austin, Tex.)|October 14, 2008
Role of hERG potassium channel assays in drug developmentBirgit T Priest, Ian M Bell, Maria L Garcia
Elife|May 17, 2017
Voltage-gated Na<sup>+</sup> currents in human dorsal root ganglion neuronsXiulin Zhang, Birgit T Priest, Inna Belfer, et al.
Assay and Drug Development Technologies|December 31, 2015
Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks BarracudaRok Cerne, Mark Wakulchik, Baolin Li, et al.
The Journal of General Physiology|April 16, 2008
Ion channels as drug targets: the next GPCRsGregory J Kaczorowski, Owen B McManus, Birgit T Priest, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Opinion in Drug Discovery & Development|September 9, 2009
Future potential and status of selective sodium channel blockers for the treatment of painBirgit T Priest
Future Medicinal Chemistry|October 28, 2017
The therapeutic potential of targeting the K<sub>ir</sub>1.1 (renal outer medullary K<sup>+</sup>) channelBirgit T Priest, Alexander Pasternak
Frontiers in Pharmacology|December 19, 2014
Phenotypic screening in the 21st centuryBirgit T Priest, Gul Erdemli
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Subtype-selective sodium channel blockers promise a new era of pain researchBirgit T Priest, Gregory J Kaczorowski
Expert Opinion on Therapeutic Targets|February 15, 2007
Blocking sodium channels to treat neuropathic painBirgit T Priest, Gregory J Kaczorowski
Channels (Austin, Tex.)|November 12, 2015
Cardiac ion channelsBirgit T Priest, Jeff S McDermott
Channels (Austin, Tex.)|October 14, 2008
Role of hERG potassium channel assays in drug developmentBirgit T Priest, Ian M Bell, Maria L Garcia
Elife|May 17, 2017
Voltage-gated Na<sup>+</sup> currents in human dorsal root ganglion neuronsXiulin Zhang, Birgit T Priest, Inna Belfer, et al.
Assay and Drug Development Technologies|December 31, 2015
Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks BarracudaRok Cerne, Mark Wakulchik, Baolin Li, et al.
The Journal of General Physiology|April 16, 2008
Ion channels as drug targets: the next GPCRsGregory J Kaczorowski, Owen B McManus, Birgit T Priest, et al.
Pageof 6